@article{TLCR18496,
author = {Jun Qian and Pierre P. Massion},
title = {Next-generation molecular therapy in lung cancer},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 1},
year = {2018},
keywords = {},
abstract = {The identification of molecular subsets of non-small cell lung cancer (NSCLC) has completely modified our approach to the management of this disease. NSCLC is the most common type of lung cancer (80–85%), which is the number one cancer killer in the nation and worldwide (1). NSCLC can be further pathologically divided into two main subtypes including adenocarcinoma (ADC, 40%) and squamous cell carcinoma (SCC, 25%).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/18496}
}